Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium

Nicholas P. Campbell, Rangesh Kunnavakkam, Natasha Leighl, Mark D. Vincent, David R Gandara, Marianna Koczywas, Barbara J. Gitlitz, Edem Agamah, Sachdev P. Thomas, Walter M. Stadler, Everett E. Vokes, Hedy L. Kindler

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium'. Together they form a unique fingerprint.

Medicine & Life Sciences